What the current label tells users
- Do not exceed the recommended dose.
- Pregnant or nursing mothers should consult a physician.
- People under 18 should consult a physician.
- Individuals with a known medical condition should consult a physician.
- Keep out of reach of children.
- Do not use if the safety seal is damaged or missing.
- Store in a cool, dry place.
Medication interaction focus
Ginkgo deserves special attention because NCCIH says it may increase bleeding risk with warfarin and may interact with other medicines. Turmeric/curcumin products can also interact with medications, and NCCIH advises discussing herbal products with healthcare providers.
FDA regulation context
FDA does not approve dietary supplements for safety and effectiveness before they are marketed. Manufacturers and distributors are responsible for product safety, truthful labeling and compliance. That is why “FDA approved supplement” is not an appropriate trust claim.
AREDS2 is not a generic label for eye supplements
If a clinician recommends an AREDS2 formula for diagnosed AMD, NEI advises checking the exact ingredient amounts. The current iGenics label does not match the NEI AREDS2 amounts, so it should not automatically be substituted for an AREDS2 product based on overlapping ingredients alone.
Eye-care red flags
Seek timely professional care for sudden vision changes, new flashes/floaters, eye injury, severe pain or symptoms that worry you. Supplements are not emergency treatment.
References & source notes
- NCCIH — Ginkgo: Usefulness and Safety
- NCCIH — Turmeric: Usefulness and Safety
- NIH Office of Dietary Supplements — Zinc
- FDA — Information for Consumers on Using Dietary Supplements
- FDA — Is It Really “FDA Approved”?
- National Eye Institute — AREDS2 Supplements for AMD
Independent ingredient research does not establish that the finished iGenics product has been clinically proven. Product-specific facts on this site are taken from the current vendor-provided label and offer materials supplied for this build.